Concomitantly, the M2 marker genes ARG1, CD163, and CD206 as well as the gene encoding the anti-inflammatory cytokine IL10 were all increased in monocytes of healthy subjects and MS patients following MP treatment, although the differences were not always statistically significant (Figures 4C–F). Here, IL10 is linked to myeloid sarcoma.